OKLAHOMA CITY, OK--(Marketwire - May 24, 2012) - Graymark Healthcare, Inc. (NASDAQ: [ GRMH ]), a provider of care management solutions to the sleep disorder market, announced today that it has engaged Genesis Select for investor relations services.

Genesis Select will support Graymark's efforts to cultivate long-term relationships with the investment community by helping Wall Street gain a broader understanding of the company's growth and value proposition and its role in providing sleep testing services and care management solutions to people with chronic sleep disorders.

"Genesis Select is known for raising awareness of emerging small and micro-cap companies. We are focused on a large and growing demographic trend and building our business by improving our conversion rates, and increasing volume at our facilities. We will look to Genesis to convey our story to the street, and communicate our future opportunities as we expand into complementary markets," said Stanton Nelson, chief executive officer of Graymark.

"We look forward to working with Stanton and his team at Graymark," said Budd Zuckerman, president of Genesis Select. "We believe that Graymark has a distinctive story, providing superior sleep disorder solutions that meet the needs of patients and doctors seeking reliable results and improved quality of life for the 50 million Americans that suffer from sleep ailments."

About Graymark Healthcare, Inc.

Headquartered in Oklahoma City, Okla., Graymark Healthcare, Inc. (NASDAQ: [ GRMH ]) is the nation's second largest provider of sleep management solutions. In addition to diagnosing and treating over 80 sleep disorders, the company specializes in comprehensive care for Obstructive Sleep Apnea (OSA). Graymark offers its services through 105 sleep laboratories primarily in the Midwest, including standalone or IDTF facilities, therapy facilities, rural outreach hospital sites and urban hospital management agreements. For more information, visit [ www.graymarkhealthcare.com ].